Verismo-HLB Innovation Merger to Accelerate KIR-CAR Cancer Treatment

Verismo Therapeutics and HLB Innovation will expedite the clinical advancement of SynKIR-110 and SynKIR-310 for patients with solid tumors and blood cancers, respectively, reinforcing the shared goal of Verismo and HLB Group to promote their...

Rising Demand for Advanced Drug Delivery Boosts Pharmaceutical Excipient Market

The growth of the pharmaceutical excipient market is driven by the rising use of advanced drug delivery systems, biologics, and drug formulations focused on patient needs. The market is projected to increase from US$ 972.9 million in 2024 to US$...

Advancements and Regulations Drive Growth in Pharma Processing Seals Market

The expansion of the pharmaceutical processing seals market is influenced by multiple factors, such as the rising intricacy of drug production, strict regulatory standards, and developments in drug delivery systems. A primary factor is the...

USFDA Approves Pfizer's BRAFTOVI Combo for BRAF V600E mCRC

Pfizer Inc revealed that the US Food and Drug Administration (FDA) has authorized BRAFTOVI (encorafenib) alongside cetuximab (sold as ERBITUX) and mFOLFOX6 (fluorouracil, leucovorin, and oxaliplatin) for treating patients with metastatic...

Pharma Exports Surge to Rs 2.3 Lakh Crore in FY24, Doubling Since FY14

In the financial year 2024, India's pharmaceutical exports totaled Rs 2.3 lakh crore, an increase from Rs 1.1 lakh crore in FY14. Pharma exports increased by 8.36% from Rs 17,750 crore in July 2023 to Rs 18,670 crore in July 2024. The government...

India's Pharma Industry Leads as a Top Investment Market

The pharmaceutical sector in India ranks among the leading industries drawing investments. India's healthcare and pharmaceutical industries secured Rs 14,811 crore through initial public offerings (IPOs) in 2024, marking the highest amount since...

India's Medical Device Sector Emerges as a Sunrise Market

The medical device sector in India is recognized as a sunrise sector because of its immense growth potential driven by the country's increasing healthcare needs, technological innovations, government support, and emerging market opportunities, as...

US FDA Fast Tracks Lipocine's LPCN 1148 for Sarcopenia in Liver Cirrhosis

Lipocine Inc., a biopharmaceutical company utilizing its own technology platform to enhance therapeutics via efficient oral delivery, reported that the US Food and Drug Administration (FDA) has awarded Fast Track Designation to LPCN 1148 for...

India's Pharma Market Hits $50 Billion, 3rd Globally in FY 2023-24

India's pharmaceutical sector, ranked as the third largest in the world by volume, was valued at $50 billion in the fiscal year 2023-24, as per Union Minister of State for Chemicals and Fertilizers Anupriya Patel. The domestic consumption value of...

Chronic Diseases Fuel Surge in Biologics CDMO Secondary Packaging Market

The secondary packaging market for biologics CDMO is undergoing considerable expansion owing to the rising incidence of chronic illnesses globally. As chronic diseases become more common, the necessity for novel therapies and precision medicine...

© 2025 India Pharma Outlook. All Rights Reserved.